Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bourn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Design, Development and Therapy|June 27, 2018
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitroJennifer Bourn, Maria Cekanova
Oncotarget|July 10, 2018
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cellsSony Pandey, Jennifer Bourn, Maria Cekanova
Journal of Cellular Biochemistry|September 21, 2016
Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In VitroDmitriy Smolensky, Kusum Rathore, Jennifer Bourn, et al.
Oncotarget|September 10, 2019
Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib AJennifer Bourn, Sony Pandey, Jashim Uddin, et al.
BMC Cancer|November 29, 2019
Detection of carcinogen-induced bladder cancer by fluorocoxib AJennifer Bourn, Kusum Rathore, Robert Donnell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Design, Development and Therapy|June 27, 2018
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitroJennifer Bourn, Maria Cekanova
Oncotarget|July 10, 2018
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cellsSony Pandey, Jennifer Bourn, Maria Cekanova
Journal of Cellular Biochemistry|September 21, 2016
Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In VitroDmitriy Smolensky, Kusum Rathore, Jennifer Bourn, et al.
Oncotarget|September 10, 2019
Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib AJennifer Bourn, Sony Pandey, Jashim Uddin, et al.
BMC Cancer|November 29, 2019
Detection of carcinogen-induced bladder cancer by fluorocoxib AJennifer Bourn, Kusum Rathore, Robert Donnell, et al.
Pageof 1